|
GEMIN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0910000014519E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.06050004730929E-09 |
| Normal-vs-Stage2 |
3.041400E-04 |
| Normal-vs-Stage3 |
8.20109999910557E-08 |
| Normal-vs-Stage4 |
1.28249999953312E-07 |
| Stage1-vs-Stage2 |
1.940350E-01 |
| Stage1-vs-Stage3 |
1.952170E-01 |
| Stage1-vs-Stage4 |
7.027200E-01 |
| Stage2-vs-Stage3 |
6.000000E-01 |
| Stage2-vs-Stage4 |
1.867810E-01 |
| Stage3-vs-Stage4 |
2.545200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.28060000276409E-08 |
| Normal-vs-AfricanAmerican |
1.802220E-03 |
| Normal-vs-Asian |
1.83119999996872E-06 |
| Caucasian-vs-AfricanAmerican |
3.787000E-01 |
| Caucasian-vs-Asian |
8.372400E-01 |
| AfricanAmerican-vs-Asian |
4.989800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06270003907838E-09 |
| Normal-vs-Female |
1.56780000093448E-08 |
| Male-vs-Female |
7.458200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.4383000325231E-09 |
| Normal-vs-Age(41-60Yrs) |
1.4082000010518E-09 |
| Normal-vs-Age(61-80Yrs) |
1.01030000032587E-07 |
| Normal-vs-Age(81-100Yrs) |
1.813630E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.894200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.332600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.299800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.469200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.208000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.416400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.744500E-02 |
| Classical-VS-Follicular |
1.084970E-03 |
| Classical-VS-Other |
3.059800E-01 |
| Classical-VS-Normal |
5.89729999944666E-07 |
| Tall-VS-Follicular |
4.508400E-01 |
| Tall-VS-Other |
8.859200E-01 |
| Tall-VS-Normal |
1.22869999952258E-07 |
| Follicular-VS-Other |
8.333400E-01 |
| Follicular-VS-Normal |
9.85680426168756E-11 |
| Other-VS-Normal |
7.641000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.12450004863263E-09 |
| Normal-vs-N1 |
6.79640010936566E-10 |
| N0-vs-N1 |
2.502300E-02 |
|
|
